Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Hemab Therapeutics Holdings, Inc. (COAG) had Weighted-Average Shares Outstanding (Basic) of 30.11M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-24.15M |
|
-- |
|
-- |
|
$26.08M |
|
$-26.08M |
|
$2.03M |
|
$-24.05M |
|
$-24.05M |
|
$-24.15M |
|
$-24.15M |
|
$-24.15M |
|
$-24.15M |
|
$-26.08M |
|
$-26.00M |
|
|
Weighted-Average Shares Outstanding (Basic) |
30.11M |
30.11M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$464.00M |
|
$0.60M |
|
$3.78M |
|
$467.78M |
|
$12.94M |
|
-- |
|
$0.57M |
|
$13.51M |
|
$454.27M |
|
$454.27M |
|
$454.27M |
|
46.71M |
|
| Cash Flow Statement Financials | |
$-44.22M |
|
$-123.28M |
|
$317.12M |
|
$87.97M |
|
$237.37M |
|
$149.39M |
|
$3.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.32% |
|
-5.32% |
|
-5.16% |
|
-5.32% |
|
$9.73 |
|
$-1.47 |
|
$-1.47 |
|